Xcout Intel
Owkin
Owkin builds artificial intelligence solutions to automate biopharmaceutical research and development and support clinical research. Its core product, K Pro, is an AI agent that analyzes multimodal patient data to generate insights, inform decision-making, and assist biopharma and healthcare professionals.
Subscribe to see Owkin’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Owkin at a glance
Owkin is a biotech company headquartered in France. Xcout recorded 6 job postings from Owkin in the last 90 days, naming tools such as Salesforce.
Hiring at Owkin
Xcout recorded 6 job postings from Owkin in the last 90 days, from a hiring record Xcout has kept since June 2026.
Tools named in Owkin's job postings
The weekly hiring trend, the roles and locations behind it — see Owkin's hiring signals →
Tech stack
Owkin competitors
A few of Owkin's closest competitors — see the full list of competitors and alternatives →
PhaseV uses causal machine learning and generative AI to optimize clinical trial designs and improve drug development processes.
Biorce is a biotechnology research company headquartered in Barcelona, Spain, with a team of around 180 employees. The company develops artificial intelligence platforms and operating systems designed to automate and streamline clinical trials with built-in review processes and human oversight.
ArcaScience is a pharmaceutical artificial intelligence company headquartered in Paris, France, that develops an advanced benefit-risk decision engine and drug safety platforms.
Aira Health is a biotechnology research company based in Boston, Massachusetts, that provides a unified AI platform for clinical trial design and protocol development.
Pathos AI, Inc. is an artificial-intelligence-driven biopharmaceutical company that uses multimodal patient and biological data to discover and develop precision medicines. Its work is focused primarily on oncology and serves patients with serious diseases through pharmaceutical and healthcare partnerships.
BenevolentAI provides an artificial intelligence platform and life science intelligence tools designed to assist scientists and pharmaceutical executives in drug discovery and research and development decision-making. The company leverages proprietary technology and machine learning to analyze biological data and support complex R&D processes.
Get Owkin's news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on Owkin in Xcout Intel
- Weekly hiring history and the mix of roles behind it
- The full competitor set, tracking, exports and API access